Creative Financial Designs’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68 Hold
40
﹤0.01% 2137
2025
Q4
$79 Hold
40
﹤0.01% 2035
2025
Q3
$116 Hold
40
﹤0.01% 2020
2025
Q2
$72 Sell
40
-80
-67% -$142 ﹤0.01% 1990
2025
Q1
$180 Sell
120
-32
-21% -$81 ﹤0.01% 1989
2024
Q4
$359 Hold
152
﹤0.01% 1745
2024
Q3
$4.47K Hold
152
﹤0.01% 1405
2024
Q2
$1.88K Hold
152
﹤0.01% 1486
2024
Q1
$3.08K Buy
152
+12
+9% +$276 ﹤0.01% 1415
2023
Q4
$3.15K Hold
140
﹤0.01% 1348
2023
Q3
$2.33K Hold
140
﹤0.01% 1320
2023
Q2
$3.43K Hold
140
﹤0.01% 1238
2023
Q1
$3.38K Hold
140
﹤0.01% 1187
2022
Q4
$4.14K Hold
140
﹤0.01% 1072
2022
Q3
$6K Hold
140
﹤0.01% 1009
2022
Q2
$4K Hold
140
﹤0.01% 1062
2022
Q1
$5K Buy
140
+130
+1,300% +$5.51K ﹤0.01% 1052
2021
Q4
$0 Buy
+10
New +$524 ﹤0.01% 1408

Other funds holding FLNA

Creative Financial Designs's FLNA Position: Q1 2026 in Review

Creative Financial Designs held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 40 shares worth $68. The position accounts for ﹤0.01% of the portfolio, ranked #2137.

Creative Financial Designs first reported a position in FLNA in Q4 2021 and has held it in 18 quarters since. The position peaked at $6K in Q3 2022. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Creative Financial Designs held 40 shares of Filana Therapeutics worth $68 as of Q1 2026.
  • Creative Financial Designs left its Filana Therapeutics share count unchanged in Q1 2026.
  • Filana Therapeutics made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #2137 holding.
  • Creative Financial Designs first reported a position in Filana Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • Creative Financial Designs's Filana Therapeutics position peaked at $6K in Q3 2022.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.